Frustration Runs Deep For Customers Forced To Change Marketplace Plans Routinely
(By Jordan Rau for Kaiser Health News) Andrea Schankman’s three-year relationship with her insurer, Coventry Health Care of Missouri, has
Read More
What side effects? Most consumers don’t read drug risk information
(By Ed Silverman for STAT) How much attention do people pay to the risk information for prescription drugs? If you
Read MoreCMS releases MACRA final rule: 10 things to know
(By Emily Rappleye for Becker’s Hospital Review) After a listening tour and nearly 4,000 public comments, CMS released the final
Read MoreInsurers pay more for multiple sclerosis drug because rebates don’t help, report says
(By Ed Silverman for STAT) Drug makers may offer rebates to payers, but health plans continue to see notable increases
Read MoreSkeptics Question The Value Of Hydration Therapy For The Healthy
(By Taunya English for NPR) Yana Shapiro is a partner at a Philadelphia law firm, has an exhausting travel schedule
Read MoreYou Can Monitor Your Heart With A Smartphone. But Should You?
(By Erin Ross for NPR) Digital gizmos can monitor your heart, whether it’s a wrist-worn fitness tracker or a smartphone
Read MoreThe Road Ahead for Social Security–A Summation of the Situation
The long-term dilemma faced by the Social Security and Medicare Trust Funds is not a self-correcting situation, and most Americans
Read MoreWaste from pharmaceutical plants in India and China promotes antibiotic-resistant superbugs
(By Henry A. Waxman and Bill Corr for STAT) Superbugs, disease-causing microbes that have mutated to become resistant to antibiotics,
Read MoreThe insulin market is heading for a shakeup. But patients may not benefit
(By Rebecca Robbins for STAT) The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of
Read MoreWhy Is The News About TB So Bad?
(By Rina Shalkh-Lasko for NPR) Many countries think of TB as a disease of the past and this lack of
Read More